EUVIMEDEUVIMED entdecken
Crossref

Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma

Carolyn Moloney-Lineen, Devalingam Mahalingam

AME Clinical Trials Review · 2026-04 · 4 · 16-16

DOI: 10.21037/actr-25-92 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-04. Verfasst von Carolyn Moloney-Lineen und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Moloney-Lineen, C., & Mahalingam, D. (2026). Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma. AME Clinical Trials Review, 4, 16-16. https://doi.org/10.21037/actr-25-92

Vancouver

Moloney-Lineen C, Mahalingam D. Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma. AME Clinical Trials Review. 2026;4:16-16. doi:10.21037/actr-25-92

BibTeX
@article{MoloneyLineen2026,
  author = {Moloney-Lineen, Carolyn and Mahalingam, Devalingam},
  title = {Cachexia, cytokines, and caution: lessons from tocilizumab in advanced pancreatic ductal adenocarcinoma},
  journal = {AME Clinical Trials Review},
  year = {2026},
  volume = {4},
  pages = {16--16},
  doi = {10.21037/actr-25-92}
}
Kostenlos starten →